179 related articles for article (PubMed ID: 19117781)
1. IGF-I replacement therapy in children with congenital IGF-I deficiency (Laron syndrome) maintains heart dimension and function.
Scheinowitz M; Feinberg MS; Laron Z
Growth Horm IGF Res; 2009 Jun; 19(3):280-2. PubMed ID: 19117781
[TBL] [Abstract][Full Text] [Related]
2. Left ventricular mass and function in children with GH deficiency before and during 12 months GH replacement therapy.
Salerno M; Esposito V; Spinelli L; Di Somma C; Farina V; Muzzica S; de Horatio LT; Lombardi G; Colao A
Clin Endocrinol (Oxf); 2004 May; 60(5):630-6. PubMed ID: 15104568
[TBL] [Abstract][Full Text] [Related]
3. Head circumference in untreated and IGF-I treated patients with Laron syndrome: comparison with untreated and hGH-treated children with isolated growth hormone deficiency.
Laron Z; Iluz M; Kauli R
Growth Horm IGF Res; 2012 Apr; 22(2):49-52. PubMed ID: 22414926
[TBL] [Abstract][Full Text] [Related]
4. Insulinlike growth factor I affects ocular development: a study of untreated and treated patients with Laron syndrome.
Bourla DH; Laron Z; Snir M; Lilos P; Weinberger D; Axer-Siegel R
Ophthalmology; 2006 Jul; 113(7):1197.e1-5. PubMed ID: 16815402
[TBL] [Abstract][Full Text] [Related]
5. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions.
Dinleyici EC; Kilic Z; Buyukkaragoz B; Ucar B; Alatas O; Aydogdu SD; Dogruel N
Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262
[TBL] [Abstract][Full Text] [Related]
6. Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne.
Ben-Amitai D; Laron Z
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):950-4. PubMed ID: 21054577
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-I treatment of children with Laron syndrome (primary growth hormone insensitivity).
Laron Z
Pediatr Endocrinol Rev; 2008 Mar; 5(3):766-71. PubMed ID: 18367997
[TBL] [Abstract][Full Text] [Related]
8. Development and biological function of the female gonads and genitalia in IGF-I deficiency -- Laron syndrome as a model.
Laron Z
Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():188-91. PubMed ID: 16641857
[TBL] [Abstract][Full Text] [Related]
9. Consequences of not treating children with laron syndrome (primary growth hormone insensitivity).
Laron Z
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1243-8; discussion 1261-2. PubMed ID: 11964019
[TBL] [Abstract][Full Text] [Related]
10. Long-term IGF-I treatment of children with Laron syndrome increases adiposity.
Laron Z; Ginsberg S; Lilos P; Arbiv M; Vaisman N
Growth Horm IGF Res; 2006 Feb; 16(1):61-4. PubMed ID: 16442822
[TBL] [Abstract][Full Text] [Related]
11. Reduced exercise capacity in untreated adults with primary growth hormone resistance (Laron syndrome).
Ben-Dov I; Gaides M; Scheinowitz M; Wagner R; Laron Z
Clin Endocrinol (Oxf); 2003 Dec; 59(6):763-7. PubMed ID: 14974919
[TBL] [Abstract][Full Text] [Related]
12. Biphasic response of subscapular skinfold thickness to hGH or IGF-1 administration to patients with congenital IGHD, congenital MPHD and Laron syndrome.
Bisker-Kassif O; Kauli R; Lilos P; Laron Z
Obes Res Clin Pract; 2014; 8(1):e55-62. PubMed ID: 24548577
[TBL] [Abstract][Full Text] [Related]
13. Obese adults with primary growth hormone resistance (Laron Syndrome) have normal endothelial function.
Shechter M; Ginsberg S; Scheinowitz M; Feinberg MS; Laron Z
Growth Horm IGF Res; 2007 Apr; 17(2):165-70. PubMed ID: 17320443
[TBL] [Abstract][Full Text] [Related]
14. Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity).
Laron Z; Ginsberg S; Lilos P; Arbiv M; Vaisman N
Clin Endocrinol (Oxf); 2006 Jul; 65(1):114-7. PubMed ID: 16817829
[TBL] [Abstract][Full Text] [Related]
15. Hand size and growth in untreated and IGF-I treated patients with Laron syndrome.
Konen O; Silbergeld A; Lilos P; Kornreich L; Laron Z
J Pediatr Endocrinol Metab; 2009 Mar; 22(3):235-9. PubMed ID: 19492579
[TBL] [Abstract][Full Text] [Related]
16. Effects of heterozygosity for the E180 splice mutation causing growth hormone receptor deficiency in Ecuador on IGF-I, IGFBP-3, and stature.
Guevara-Aguirre J; Rosenbloom AL; Guevara-Aguirre M; Yariz K; Saavedra J; Baumbach L; Shuster J
Growth Horm IGF Res; 2007 Jun; 17(3):261-4. PubMed ID: 17350302
[TBL] [Abstract][Full Text] [Related]
17. Foot length before and during insulin-like growth factor-I treatment of children with laron syndrome compared to human growth hormone treatment of children with isolated growth hormone deficiency.
Silbergeld A; Lilos P; Laron Z
J Pediatr Endocrinol Metab; 2007 Dec; 20(12):1325-8. PubMed ID: 18341092
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic dimensions and function in adults with primary growth hormone resistance (Laron syndrome).
Feinberg MS; Scheinowitz M; Laron Z
Am J Cardiol; 2000 Jan; 85(2):209-13. PubMed ID: 10955379
[TBL] [Abstract][Full Text] [Related]
19. Effects of GH/IGF-I Axis on Retinal Vascular Morphology: Retinal Vascular Characteristics in a Clinical Setting with Severe IGF-I Deficiency.
Sekeroglu HT; Kadayıfcılar S; Kasım B; Arslan U; Ozon A
Ophthalmic Genet; 2016; 37(1):53-8. PubMed ID: 25078475
[TBL] [Abstract][Full Text] [Related]
20. Cardiac examination in children with Laron syndrome undergoing mecasermin therapy.
Erol N; Yıldız M; Güven A; Yıldırım A
J Pediatr Endocrinol Metab; 2018 Jun; 31(6):675-679. PubMed ID: 29750649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
